Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration

Clinical Cancer Research

Volumn 12, Issue 21, 2006, Pages 6331-6336

  Khwaja, Fatima W ^a   Duke Cohan, Jonathan S ^b,c   Brat, Daniel J ^a   Van Meir, Erwin G ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTRACTIN; BIOLOGICAL MARKER;

ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER GRADING; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; TUMOR CELL;

ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL MOVEMENT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS;

EID: 33751293920     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-1296     Document Type: Article

References (22)

1. Strickler R, Phillips ML. Astrocytomas: the clinical picture. Clin J Oncol Nurs 2000;4:153-8.
2. Yuan X, Desiderio DM. Proteomics analysis of human cerebrospinal fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2005;815:179-89.
3. Aldred S, Grant MM, Griffiths HR. The use of proteomics for the assessment of clinical samples in research. Clin Biochem 2004;37:943-52.
4. Steel LF, Trotter MG, Nakajima PB, et al. Efficient and specific removal of albumin from human serum samples. Mol Cell Proteomics 2003;2:262-70.
5. Kennedy S. Proteomic profiling from human samples: the body fluid alternative. Toxicol Lett 2001;120:379-84.
6. Petricoin EF III, Bichsel VE, Calvert VS, et al. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol 2005;23:3614-21.
7. Liotta LA, Ferrari M, Petricoin E. Clinical proteomics: written in blood. Nature 2003;425:905.
8. Duke-Cohan JS, Tang W, Schlossman SF. Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions. Adv Exp Med Biol 2000;477:173-85.
9. Tang W, Gunn TM, Mclaughlin DF, Barsh GS, Schlossman SF, Duke-Cohan JS. Secreted and membrane attractin result from alternative splicing of the human ATRN gene. Proc Natl Acad Sci U S A 2000;97:6025-30.
10. Tang W, Duke-Cohan JS. Human secreted attractin disrupts neurite formation in differentiating cortical neural cells in vitro. J Neuropathol Exp Neurol 2002;61:767-77.
11. Duke-Cohan JS, Gu J, McLaughlin DF, Xu Y, Freeman GJ, Schlossman SF. Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions Proc Natl Acad Sci U S A 1998;95:11336-41.
12. Goldman D, Merril CR, Ebert MH. Two-dimensional gel electrophoresis of cerebrospinal fluid proteins. Clin Chem 1980;26:1317-22.
13. Gygi SP, Rist B, Griffin TJ, et al. Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J Proteome Res 2002;1:47-54.
14. Ishii N, Maier D, Merlo A, et al. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 1999;9:469-79.
15. Duke-Cohan JS, Morimoto C, Rocker JA, Schlossman SF. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J Immunol 1996;156:1714-21.
16. Di Giovanni S, Faden AI, Yakovlev A, et al. Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth. FASEB J 2005;19:153-4.
17. Bork P, Beckmann G. The CUB domain. A wide-spread module in developmentally regulated proteins J Mol Biol 1993;231:539-45.
18. Busek P, Malik R, Sedo A. Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. Int J Biochem Cell Biol 2004;36:408-21.
19. Malik R, Mares V, Kleibl Z, Pohlreich P, Vlasicova K, Sedo A. Expression of attractin and its differential enzyme activity in glioma cells. Biochem Biophys Res Commun 2001;284:289-94.
20. Sedo A, Malik R, Vicar J, Simanek V, Ulrichova J. Quaternary benzo[c]phenanthridine alkaloids as inhibitors of dipeptidyl peptidase IV-like activity baring enzymes in human blood plasma and glioma cell lines. Physiol Res 2003;52:367-72.
21. Lu X, Gunn TM, Shieh K, Barsh GS. Akil H, Watson SJ. Distribution of Mahogany/Attractin mRNA in the rat central nervous system. FEBS Lett 1999;462:101-7.
22. Khwaja FW, Reed MS, Olson JJ, et al. Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J Proteome Res. In press.